COTELLIC DIN 02452340
Status: Marketed
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: COBIMETINIB (COBIMETINIB FUMARATE)
Available to quote
Health Canada record
| Active ingredient(s) | COBIMETINIB (COBIMETINIB FUMARATE) 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01EE02 COBIMETINIB |
| Original market date | 06-Apr-2016 |
| Current status date | 06-Apr-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 17786 | 2016-02-22 | New Drug Submission (NDS) |